NCT06359119

Brief Summary

This study consists of a survey created for intensive care physicians regarding their current practice of the implementation of apnoea test for patients with suspected brain death.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2024

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 27, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 11, 2024

Completed
20 days until next milestone

Study Start

First participant enrolled

May 1, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2024

Completed
Last Updated

May 6, 2024

Status Verified

May 1, 2024

Enrollment Period

3 months

First QC Date

March 27, 2024

Last Update Submit

May 3, 2024

Conditions

Brain Death

Keywords

brain death determinationapnoea testsurvey

Outcome Measures

Primary Outcomes (4)

  • Number of apnoea tests

    How much apnoea test is required for brain death determination.

    last 1 year

  • Timeframe between apnoea tests

    If more than 1 apnoeae test is reuired for brain death determination, how many hours should elapse between the two tests.

    last 1 year

  • Preoxygenation

    For how long (in minutes) the patient is preoxygenated before the apnoea test.

    last 1 year

  • Baseline arterial carbon dioxide (CO2) level

    What is the required arterial partial CO2 pressure (PaCO2) before apnoea testing, confirmed by arterial blood gas measurement?

    Last 1 year

Secondary Outcomes (2)

  • Detection of possible spontaneous breath movements

    last 1 year

  • Satisfaction with current practice

    last 1 year

Other Outcomes (1)

  • Continuous positive airway pressure (CPAP)

    last 1 year

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Any physician working in intensive care can fill the form and participate in the study.

You may qualify if:

  • Physicians working in intensive care units

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Brain Death

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesComaUnconsciousnessConsciousness DisordersNeurobehavioral ManifestationsNeurologic ManifestationsDeathPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Bakos Péter

CONTACT

+36207752886imaping.subdep@gmail.com

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 27, 2024

First Posted

April 11, 2024

Study Start

May 1, 2024

Primary Completion

July 31, 2024

Study Completion

July 31, 2024

Last Updated

May 6, 2024

Record last verified: 2024-05